We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAJ
1176
DELISTED
Canon, Inc.
CAJ
$3.27M 0.01%
147,073
+133,873
+1,014% +$2.94M
BDN
1177
Brandywine Realty Trust
BDN
$521M
$3.27M 0.01%
691,045
+464,123
+205% +$2.72M
EVE
1178
DELISTED
EVe Mobility Acquisition Corp
EVE
$3.25M 0.01%
311,736
-508,860
-62% -$5.27M
MTCH icon
1179
Match Group
MTCH
$9.16B
$3.25M 0.01%
+84,756
New +$3.7M
MYRG icon
1180
MYR Group
MYRG
$5.31B
$3.25M 0.01%
+25,799
New +$2.77M
DALS
1181
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$3.24M 0.01%
320,517
-576,422
-64% -$5.81M
CMBT
1182
CMB.TECH NV
CMBT
$4.47B
$3.24M 0.01%
193,023
-16,277
-8% -$271K
LUNRW
1183
CALL
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$3.24M 0.01%
300,000
-30,000
-9% -$15.2K
LQD icon
1184
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$3.23M 0.01%
+29,500
New +$3.19M
LFACW
1185
CALL
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$3.23M 0.01%
307,457
ACMR icon
1186
ACM Research
ACMR
$4.98B
$3.23M 0.01%
275,920
+163,464
+145% +$1.89M
AMX icon
1187
America Movil
AMX
$77.2B
$3.22M 0.01%
+152,954
New +$3.14M
LOCC.WS
1188
CALL
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$3.2M 0.01%
316,662
JWSM.WS
1189
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$3.2M 0.01%
318,821
-98,540
-24% -$8.9K
ALKS icon
1190
Alkermes
ALKS
$8.42B
$3.2M 0.01%
113,404
FIS icon
1191
Fidelity National Information Services
FIS
$23.2B
$3.19M 0.01%
58,643
-166,604
-74% -$10.8M
NRG icon
1192
NRG Energy
NRG
$26.9B
$3.19M 0.01%
92,906
-321,540
-78% -$10.6M
UTZ icon
1193
Utz Brands
UTZ
$1.25B
$3.18M 0.01%
193,216
-65,274
-25% -$1.08M
STVN icon
1194
Stevanato
STVN
$5.5B
$3.18M 0.01%
+122,791
New +$2.63M
PANA
1195
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$3.18M 0.01%
311,568
-497,161
-61% -$5.04M
SNRHW
1196
CALL
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$3.16M 0.01%
314,858
-172,739
-35% -$11K
SPLV icon
1197
Invesco S&P 500 Low Volatility ETF
SPLV
$7.28B
$3.16M 0.01%
50,600
+41,800
+475% +$2.61M
ADUS icon
1198
Addus HomeCare
ADUS
$2.23B
$3.14M 0.01%
+29,449
New +$3.07M
PACW
1199
DELISTED
PacWest Bancorp
PACW
$3.14M 0.01%
+322,259
New +$7.17M
CRGY icon
1200
Crescent Energy
CRGY
$3.44B
$3.13M 0.01%
276,468
-86,947
-24% -$1.01M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.